PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CORONAVIRUS DISEASE 19, CONTAINING CARBOCYCLIC NUCLEOSIDE DERIVATIVE

The present invention relates to a pharmaceutical composition for prevention or treatment of coronavirus disease 19 (COVID-19) and, specifically, to a pharmaceutical composition containing a carbocyclic nucleoside derivative represented by chemical formula A-1 or chemical formula A-2 or a pharmaceut...

Full description

Saved in:
Bibliographic Details
Main Authors KANG, JI YOON, SON, SEO HYUN, SEO, SEONG WOOK, LEE, HYUK WOO, JANG, HYU JEONG
Format Patent
LanguageEnglish
French
Published 01.09.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a pharmaceutical composition for prevention or treatment of coronavirus disease 19 (COVID-19) and, specifically, to a pharmaceutical composition containing a carbocyclic nucleoside derivative represented by chemical formula A-1 or chemical formula A-2 or a pharmaceutically acceptable salt thereof. La présente invention concerne une composition pharmaceutique pour la prévention ou le traitement du coronavirus 19 (COVID-19) et, plus particulièrement, une composition pharmaceutique contenant un dérivé de nucléoside carbocyclique représenté par la formule chimique A-1 ou la formule chimique A-2 ou un sel pharmaceutiquement acceptable de celui-ci.
Bibliography:Application Number: CA20223208876